A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer-Reference-Cited by-同舟云学术

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Published:2019-05-31 Issue:18 Volume:125 Page:3184-3197
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Patil Vijay Maruti¹,Noronha Vanita¹,Joshi Amit¹,Agarwal Jaiprakash²,Ghosh‐Laskar Sarbani²^ORCID,Budrukkar Ashwini²,Murthy Vedang²,Gupta Tejpal²^ORCID,Mahimkar Manoj³,Juvekar Shashikant⁴,Arya Supreeta⁴,Mahajan Abhishek⁴,Agarwal Archi⁵,Purandare Nilendu⁵,Rangarajan Venkatesh⁵,Balaji Arun⁶,Chaudhari Sameer Vasant⁷,Banavali Shripad¹,Kannan Sadhana⁸,Bhattacharjee Atanu⁹,D’Cruz Anil K.¹⁰,Chaturvedi Pankaj¹⁰^ORCID,Pai Prathamesh S.¹⁰,Chaukar Devendra¹⁰,Pantvaidya Gouri¹⁰,Nair Deepa¹⁰,Nair Sudhir¹⁰,Deshmukh Anuja¹⁰,Thiagarajan Shivakumar¹⁰,Mathrudev Vijayalakshmi¹,Manjrekar Aparna¹,Dhumal Sachin¹,Maske Kamesh¹,Bhelekar Arti Sanjay¹,Nawale Kavita¹,Chandrasekharan Arun¹,Pande Nikhil¹,Goel Alok¹,Talreja Vikas¹,Simha Vijai¹,Srinivas Sujay¹,Swami Rohit¹,Vallathol Dilip Harindran¹,Dsouza Hollis¹,Shrirangwar Sameer¹,Turkar Siddharth¹,Abraham George¹,Thanky Aditi Harsh¹,Patel Usha³,Pandey Manish Kumar³,Prabhash Kumar¹^ORCID

Affiliation:

1. Department of Medical Oncology Tata Memorial Hospital, Homi Bhabha National Institute (HBNI) Mumbai India

2. Department of Radiation Oncology Tata Memorial Hospital, HBNI Mumbai India

3. Mahimkar Laboratory Advanced Center for Treatment, Research, and Education in Cancer Navi Mumbai India

4. Department of Radiology Tata Memorial Hospital, HBNI Mumbai India

5. Department of Nuclear Medicine Tata Memorial Hospital, HBNI Mumbai India

6. Department of Speech and Therapy Tata Memorial Hospital, HBNI Mumbai India

7. Biocon Ltd Bengaluru India

8. Department of Biostatistics Advanced Center for Treatment, Research, and Education in Cancer Navi Mumbai India

9. Department of Epidemiology Advanced Center for Treatment, Research, and Education in Cancer Navi Mumbai India

10. Department of Head and Neck Surgery Tata Memorial Hospital, HBNI Mumbai India

Funder

Biocon

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32179

Reference49 articles.

1. Head and Neck Cancers, Version 2.2013

2. Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

4. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

5. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of failure after salvage head and neck surgery;Oral Oncology;2024-10

2. Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics;Protein Science;2024-09-14

3. Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis;Current Cancer Drug Targets;2024-09

4. The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy;BMC Cancer;2024-08-02

5. Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment;Cancer Letters;2024-08